Susceptibility to mycobacterial infections: The importance of host genetics

Genes and Immunity

Volumn 4, Issue 1, 2003, Pages 4-11

  Bellamy, R ^a  

^a SINGLETON HOSPITAL   (United Kingdom)

Author keywords

Genetic susceptibility; IFN R; Mycobacteria; NRAMP; Tuberculosis; VDR

Indexed keywords

BCG VACCINE; COD LIVER OIL; GAMMA INTERFERON; INTERLEUKIN 12 RECEPTOR; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; PROTEIN P40; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR; TUBERCULOSTATIC AGENT; VITAMIN D; VITAMIN D RECEPTOR;

ATYPICAL MYCOBACTERIOSIS; CHROMOSOME 15; DRUG MECHANISM; GENE IDENTIFICATION; GENETIC CODE; GENETIC LINKAGE; HOST SUSCEPTIBILITY; HUMAN; IMMUNOGENETICS; INFECTION RESISTANCE; INFECTION SENSITIVITY; LEISHMANIASIS; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; MYCOBACTERIOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLOSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUBERCULOSIS; X CHROMOSOME; ANIMAL; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MICROBIOLOGY; MYCOBACTERIUM; PATHOGENICITY;

CORYNEBACTERINEAE; SALMONELLA;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, NATURAL; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS;

EID: 0038805137     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363915     Document Type: Review

References (138)

1. Sorensen TIA, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318: 727-732.
2. Haldane JBS. Disease and evolution. La Ricerca Sci 1949; 19 (Suppl): 68-76.
3. Waksman SA. The Conquest of Tuberculosis. University of California: Berkeley, 1964.
4. Hill AVS. Malaria resistance genes: a natural selection. Trans R Soc Med Hyg 1992; 86: 225-232.
5. Weatherall DJ. Host genetics and infectious disease. Parasitology 1996; 112: S23-S29.
6. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull IUATLD 1990; 65: 6-24.
7. Dubos R, Dubos J. The White Plague: Tuberculosis, Man and Society. Little, Brown and Co.: Boston, 1952.
8. Motulsky AG. Metabolic polymorphisms and the role of infectious diseases in human evolution. Hum Biol 1960; 32: 28-62.
9. O'Brien SJ. Ghetto legacy. Curr Biol 1991; i: 209-211.
10. Budd W. The nature and the mode of propagation of phthisis. Lancet 1867; ii: 451-452.
11. Cummins SL. Tuberculosis in the Egyptian army. Br J Tuberc 1908; ii: 35-46.
12. Millar JG. On the spread and prevention of tuberculosis in Pondoland, South Africa. BMJ 1908; i: 380-382.
13. Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990; 322: 422-427.
14. Kallmann FJ, Reisner D. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tubere 1942; 47: 549-574.
15. Simonds B. Tuberculosis in Twins. Pitman Medical Publishing Company: London, 1963.
16. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit study. Am Rev Respir Dis 1978; 117: 621-624.
17. Lurie MB. Hereditary, constitution and tuberculosis. An experimental study. Am Rev Tuberc 1941; 44 (suppl): 1-125.
18. Lurie MB. Experimental epidemiology of tuberculosis. Hereditary resistance to attack by tuberculosis and to the ensuing disease and to the effect of the concentration of tubercle bacilli upon these two phases of resistance. J Exp Med 1944; 79: 573-589.
19. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
20. Gros F, Skamene E, Forget A. Genetic control of natural resistance to Mycobacterium bovis BCG. J Immunol 1981; 127: 417-421.
21. Forget A, Skamene E, Gros P, Miailhe A-E, Turcott R. Differences in response among inbred mouse strains to infection with small doses of Mycobacterium bovis BCG. Infect Immun 1981; 32: 42-47.
22. Skamene E, Gros P, Forget A, Kongshavn PAL, St-Charles C, Taylor BA. Genetic regulation of resistance to intracellular pathogens. Nature 1982; 297: 506-509.
23. Plant JE, Glynn A. Genetics of resistance to infection with Salmonella typhimurium in mice. J Infect Dis 1976; 133: 72-78.
24. Plant JE, Glynn AA. Locating Salmonella resistance gene on mouse chromosome 1. Clin Exp Immunol 1979; 37:1-6.
25. Bradley DJ. Genetic control of Leishmania populations within the host. II. Genetic control of acute susceptibility of mice to L. donovani infection. Clin Exp Immunol 1977; 30: 130-140.
26. Bradley DJ, Taylor BA, Blackwell JM, Evans EP, Freeman J. Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. Clin Exp Immunol 1979; 30: 130-140.
27. Plant JE, Blackwell JM, O'Brien AD, Bradley DJ, Glynn AA. Are the Lsh and Ity disease resistance genes at one locus on mouse chromosome 1? Nature 1982; 297: 510-511.
28. Skamene E, Gros P, Forget A, Kongshavn PAL, St-Charles C, Taylor BA. Genetic regulation of resistance to intracellular pathogens. Nature 1982; 297: 506-509.
29. Brown IN, Glynn AA, Plant JE. Inbred mouse strain resistance to Mycobacterium lepraemurium follows the Ity/Lsh pattern. Immunology 1982; 47: 149-156.
30. Skamene E, Gros P, Forget A, Patel PJ, Nesbitt M. Regulation of resistance to leprosy by chromosome 1 locus in the mouse. Immunogenet 1984; 19: 117-120.
31. Goto Y, Buschman E, Skamene E. Regulation of host resistance to Mycobacterium intracellulare in vivo and in vitro by the Bcg gene. Immunogenet 1989; 30: 218-221.
32. Lissner CR, Swanson RN, O'Brien AD. Genetic control of innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J Immunol 1983; 131: 3006-3013.
33. Crocker PR, Blackwell JM, Bradley DJ. Expression of the natural resistance gene Lsh in resident liver macrophages. Infect Immun 1984; 43: 1033-1040.
34. Stach JL, Gros P, Forget A, Skamene E. Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG). J Immunol 1984; 132: 888-892.
35. Denis M, Forget A, Pelletier M, Gervais F, Skamene E. Killing of Mycobacterium smegmatis by macrophages from genetically susceptible and resistant mice. J Leuk Biol 1990; 47: 25-30.
36. Malo D, Vidal SM, Hu J, Skamene E, Gros P. High resolution linkage map in the vicinity of the host resistance locus Bcg. Genomics 1993; 16: 655-663.
37. Gros P, Malo D. A reverse genetics approach to Bcg/Ity/Lsh gene cloning. Res Immunol 1989; 140: 774-777.
38. Malo D, Vidal S, Lieman JH, Ward DC, Gros P. Physical delineation of the minimal chromosomal segment encompassing the murine host resistance locus Bcg. Genomics 1993; 17:667-675.
39. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate gene for Bcg. Cell 1993; 73: 469-485.
40. 2-terminal sequence of macrophage-expressed natural resistance-associated macrophage protein (Nramp) encodes a proline/serine-rich putative Src homology 3-binding domain. J Exp Med 1994; 179: 1683-1687.
41. Govoni G, Vidal S, Cellier M, Lepage P, Malo D, Gros P. Genomic structure, promoter sequence, and induction of expression of the mouse Nramp1 gene in macrophages. Genomics 1995; 27: 9-19.
42. D169) mouse strains. J Immunol 1996; 157: 3559-3568.
43. Malo D, Vidal S, Skamene E et al. Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics 1994; 23: 51-61.
44. Vidal S, Tremblay ML, Govoni G et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med 1995; 182: 655-666.
45. G169 allele. Infect Immun 1996; 64: 2923-2929.
46. Cellier M, Govoni G, Vidal S et al. Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression. J Exp Med 1994; 180: 1741-1752.
47. Blackwell JM, Barton H, White JK et al. Genomic organization and sequence of the human NRAMP gene: identification and mapping of a promoter region polymorphism. Mol Med 1995; 1: 194-205.
48. Gruenheid S, Cellier M, Vidal S, Gros P. Identification and characterization of a second mouse Nramp gene. Genomics 1995; 25: 514-525.
49. Dosik JK, Barton CH, Holiday DL, Krall MM, Blackwell JM, Mock BA. An Nramp-related sequence maps to mouse chromosome 17. Mammal Genome 1994; 5: 458-460.
50. Vidal S, Belouchi A-M, Cellier M, Beatty B, Gross P. Cloning and characterization of a second human NRAMP gene on chromosome 12q13. Mammal Genome 1995; 6: 224-230.
51. Kishi F, Tabuchi M. Human natural resistance-associated macrophage protein 2: gene cloning and protein identification. Biochem Biophys Res Commun 1998; 251: 775-783.
52. Cellier M, Belouchi A, Gros P. Resistance to intracellular infections: comparative genomic analysis of Nramp. Trends Genet 1996; 12: 201-205.
53. Supek F, Supekova L, Nelson H, Nelson N. A yeast manganese transporter related to the macrophage protein involved in conferring resistance to mycobacteria. Proc Natl Acad Sci USA 1996; 93: 5105-5110.
54. Gunshin H, Mackenzie B, Berger UV et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482-488.
55. Fleming MD, Trenor CC 3rd, Su MA et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997; 16: 383-386.
56. Fleming MD, Romano MA, Su MA Garrick LM, Garrick MD, Andrews NC. Nramp2 is mutated in the anaemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA 1998; 95: 1148-1153.
57. Gruenheid S, Canonne-Hergaux F, Gauthier S, Hackam DJ, Grinstein S, Gros P. The iron transport protein Nramp2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J Exp Med 1999; 189: 831-841.
58. Tabuchi M, Yoshimori T, Yamaguchi K, Yoshida T, Kishi F. Human NRAMP2/DMT1, which mediates iron transport across membranes, is localized to late endosomes and lysosomes in Hep-2 cells. J Biol Chem 2000; 275: 22 220-22 228.
59. Gruenheid S, Pinner E, Desjardins M, Gros P. Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J Exp Med 1997; 185: 717-730.
60. Atkinson PGP, Blackwell JM, Barton CH. Nramp1 locus encodes a 65 kDa interferon-γ-inducible protein in murine macrophages. Biochem J 1997; 325: 779-786.
61. Gomes MS, Appelberg R. Evidence for a link between iron metabolism and Nramp1 gene function in innate resistance against Mycobacterium avium. Immunology 1998; 95: 165-168.
62. Gordeuk VR, McLaren CE, MacPhail AP, Deichsel G, Bothwell TH. Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited. Blood 1996; 87: 3470-3476.
63. Agranoff D, Monahan IM, Mangan JA, Butcher PD, Krishna S. Mycobacterium tuberculosis expresses a novel pH-dependent divalent cation transporter belonging to the Nramp family. J Exp Med 1999; 190: 717-724.
64. Liu J, Fujiwara M, Buu NT et al. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet 1995; 56: 845-853.
65. Abel L, Sanchez FO, Oberti J et al. Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis 1998; 177: 133-145.
66. Shaw MA, Collins A, Peacock CS ef al. Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: linkage study of the candidate genes NRAMP1 and TNFA. Tuberc Lung Dis 1997; 78: 35-45.
67. Greenwood CM, Fujiwara TM, Boothroyd LJ et al. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet 2000; 67: 405-416.
68. Roger M, Levee G, Chanteau S, Gicquel B, Schurr E. No evidence for linkage between leprosy susceptibility and the human natural resistance-associated macrophage protein 1 (NRAMP1) gene in French Polynesia. Int J Leprosy 1997; 65: 197-202.
69. Bellamy R, Beyers N, McAdam KPWJ et al. Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci USA 2000; 97: 8005-8009.
70. Medina E, North RJ. Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis. J Exp Med 1996; 183: 1045-1051.
71. Bellamy R, Ruwende C, Corrah T, McAdam KPWJ, Whittle HC, Hill AVS. Variation in the human NRAMP1 gene and human tuberculosis in an African population. N Engl J Med 1998; 338: 640-644.
72. Gao P-S, Fujishima S, Mao X-Q et al. Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. Clin Genet 2000; 58: 74-76.
73. Ryu S, Park YK, Bai GH, Kim SJ, Park SN, Kang S. 3′UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans. Int J Tuberc Lung Dis 2000; 4: 577-580.
74. Cervino AC, Lakiss S, Sow O, Hill AV. Allelic association between the NRAMP1 gene and susceptibility to tuberculosis in Guinea-Conakry. Ann Hum Genet 2000; 64: 507-512.
75. Meisner SJ, Mucklow S, Warner G, Sow SO, Lienhardt C, Hill AV. Association of NRAMP1 polymorphism with leprosy type but not susceptibility per se in West Africans. Am J Trop Med Hyg 2001; 65: 733-735.
76. Searle S, Blackwell JM. Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J Med Genet 1999; 36: 295-299.
77. Levin M, Newport MJ, D'Souza S et al. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 1995; 345: 79-83.
78. Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335: 1941-1949.
79. Casanova J-L, Blanche S, Emile J-F et al. Idiopathic disseminated bacillus Calmette-Guerin infection: a French national retrospective study. Pediatrics 1996; 98: 774-778.
80. Jouanguy E, Altare F, Lamhamedi S et al. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 1996; 335: 1956-1961.
81. Pierre-Audigier C, Jouanguy E, Lamhamedi S et al. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon γ receptor deficiency Clin Infect Dis 1997; 24: 982-984.
82. Altare F, Jouanguy E, Lamhamedi-Cherradi S et al. A causative relationship between mutant IFNγR1 alleles and impaired cellular response to IFNγ in a compound heterozygous child. Am J Hum Genet 1998; 62: 723-726.
83. Holland SM, Dorman SE, Kwon A et al. Abnormal regulation of interferon-γ, interleukin-12, and tumour necrosis factor-α in human interferon-γ receptor 1 deficiency. J Infect Dis 1228; 178: 1095-1104.
84. Roesler J, Kofink B, Wendisch J et al. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-γ-receptor (IFNγR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp Haematol 1999; 27: 1368-1374.
85. Cunningham JA, Kellner JD, Bridge PJ et al. Disseminated bacille Calmette-Guerin infection in an infant with a novel deletion in the interferon-γ-receptor gene. Int J Tuberc Lung Dis 2000; 4: 791-749.
86. Jouanguy E, Dupuis S, Pallier A et al. In a novel form of IFNγ receptor 1 deficiency, cell surface receptors fail to bind IFN-γ. J Clin Invest 2000; 105: 1429-1436.
87. Allende LM, Lopez-Goyenes A, Paz-Artal E et al. A point mutation in a domain of gamma interferon receptor 1 provokes severe inumodeficiency. Clin Diagn Lab Immunol 2001; 8: 133-137.
88. Jouanguy E, Lamhamedi-Cherradi S, Altare F et al. Partial interferon-γ receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest 1997; 100: 2658-2664.
89. Jouanguy E, Lamhamedi-Cherradi S, Lammas D et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 1999; 21: 370-378.
90. Villela A, Picard C, Jouanguy E et al. Recurrent Mycobacterium avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation. Pediatrics 2001; 107: e47.
91. Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-γ receptor and susceptibility to mycobacterial infection. J Clin Invest 1998; 101: 2364-2369.
92. Doffinger R, Jouanguy E, Dupuis S et al. Partial interferon-γ receptor signaling chain deficiency in a patient with bacille Calmette-Guerin and Mycobacterium abscessus infection. J Infect Dis 2000; 181: 379-384.
93. Dupuis S, Dargemont C, Fieschi C et al. Impairment of mycobacterial but not viral immunity by a germline STAT1 mutation. Science 200; 293: 300-303.
94. Altare F, Durandy A, Lammas D et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280: 1432-1435.
95. de Jong R, Altare F, Haagen I-A et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998; 280: 1435-1438.
96. Verhagen CE, de Boer T, Smits HH et al. Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor β1 (IL12Rβ1): evidence for an IL12Rβ1-independent pathway of IL-12 responsiveness in human T cells. J Exp Med 2000; 192: 517-528.
97. Aksu G, Trpan C, Cavuolu C et al. Mycobacterium fortuitumchelonae complex infection in a child with complete interleukin-12 receptor β1 deficiency. Pediatr Infect Dis J 2001; 20: 551-553.
98. Altare F, Ensser A, Breiman A et al. IL-12 receptor β1 deficiency in a patient with abdominal tuberculosis. J Infect 2001; 184: 231-236.
99. Sakai T, Matsuoka M, Aoki M et al. Missense mutation of the interleukin-12 receptor β1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection. Blood 2001; 97: 2688-2694.
100. Altare F, Lammas D, Revy P et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J Clin Invest 1998; 102: 2035-2040.
101. Picard C, Fieschi C, Altare F et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 2002; 70: 336-348.
102. Dupuis S, Doffinger R, Picard C et al. Human interferon-γ-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 2000; 178: 129-137.
103. Dowling GB, Prosser-Thomas EW. Treatment of lupus vulgaris with calciferol. Lancet 1946; i: 919-922.
104. 3, gamma interferon, and control of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57: 159-163.
105. 3: a novel immunoregulatory hormone. Science 1984; 224: 1438-1440.
106. 3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984; 74: 657-661.
107. 3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology 1987; 62: 229-234.
108. Denis M. Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin Exp Immunol 1991; 84: 200-206.
109. 3 by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis. Am Rev Resp Dis 1988; 138: 984-989.
110. Strachan DP, Powell KJ, Thaker A, Millard FJC, Maxwell JD. Vegetarian diet as a risk factor for tuberculosis in immigrant south London Asians. Thorax 1995; 50: 175-180.
111. Davies PDO, Brown RC, Woodhead JS. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax 1985; 40: 187-190.
112. Grange JM, Davies PDO, Brown RC, Woodhead JS, Kardjito T. A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle 1985; 66: 187-191.
113. 3 inhabits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA 1987; 84: 3385-3389.
114. 3 receptors in human leukocytes. Science 1983; 221: 1181-1183.
115. 3. Clin Immunol Immunopathol 1989; 53: 24-31.
116. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphisms; and circulating osteocalcin. Proc Natl Acad Sci USA 1992; 89: 6665-6669.
117. Morrison NA, Qi JC, Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-287.
118. Howard G, Nguyen T, Morrison N et al. Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab 1995; 80: 2800-2805.
119. Spector TD, Keen RW, Arden NK et al. Influence of vitamin D receptor genotype on bone mineral density in premenopausal women: a twin study in Britain. BMJ 1995; 310: 1357-1360.
120. Eisman JA. Vitamin D receptor gene variants: implications for therapy. Curr Opin Genet Dev 1996; 6: 361-365.
121. Riggs BL. Vitamin-D receptor genotypes and bone mineral density. N Engl J Med 1997; 337: 125-126.
122. Bellamy R, Ruwende C, Corrah T et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179: 722-724.
123. Wilkinson RJ, Llewelyn M, Toossi Z et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis amongst Gujarati Asians in west London. Lancet 2000; 355: 618-621.
124. Roy S, Frodsham A, Saha B, Hazra SK, Mascie-Taylor CGN, Hill AVS. Association of vitamin D receptor genotype with leprosy type. J Infect Dis 1999; 179: 187-191.
125. Singh SPN, Mehra NK, Dingley HB, Pande JN, Vaidya MC. Human leukocyte antigen (HLA)-linked control of susceptibility to tuberculosis and association with HLA-DR types. J Infect Dis 1983; 148: 676-681.
126. Bothamley GH, Beck JS, Schreuder GMT et al. Association of tuberculosis and tuberculosis-specific antibody levels with HLA. J Infect Dis 1989; 159: 549-555.
127. Todd JR, West BC, McDonald JC. Human leukocyte antigen and leprosy: study in Northern Louisana and review. Rev Infect Dis 1990; 12: 63-74.
128. Brahmajothi V, Pitchappan RM, Kakkanaiah VN et al. Association of pulmonary tuberculosis and HLA in South India. Tubercle 1991; 72: 123-132.
129. Cox RA, Downs M, Neimes RE, Ognibene AJ, Yamashita TS, Ellner JJ. Immunogenetic analysis of human tuberculosis. J Infect Dis 1988; 158: 1302-1308.
130. Goldfield AE, Delgado JC, Thim S et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 1998; 279: 226-228.
131. Zerva L, Cizman B, Mehra NK et al. Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy. J Exp Med 1996; 183: 829-836.
132. Roy S, McGuire W, Mascie-Taylor CGN et al. Tumour necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis 1997; 176: 530-532.
133. Penrose LS. The general purpose sib-pair linkage test. Ann Eugen 1953; 18: 120-124.
134. Heffernan JF, Nunn AJ, Peto J, Fox W. Pulmonary tuberculosis in Scotland: a national sample survey and follow-up (1968-1970). 1 The characteristics of the patients notified in 1968. Tubercle 1975; 56: 253-267.
135. Hinman AR, Judd JM, Kolnick JP, Daitch PB. Changing risks in tuberculosis. Am J Epidemiol 1976; 103: 486-497.
136. Kustner HGV. Trends in four major communicable diseases. S Afr Med J 1979; 55: 460-473.
137. Rieder HL, Kelly GD, Bloch AB, Cauthen GM, Snider DE. Tuberculosis diagnosed at death in the United States. Chest 1991; 100: 678-681.
138. Medical Research Council Cardiothoracic Epidemiology Group. National survey of notifications of tuberculosis in England and Wales in 1988. Thorax 1992; 47: 770-775.